Economic Times
 
Bengaluru: Genomic diagnostics services company, MedGenome, announced that it has raised $47.5 million (over ₹400 crore) in its Series E funding round.
 
The investment round was co-led by private equity firm Maj Invest, an existing investor Novo Holdings and an existing shareholder Sofina.
 
“This funding will enable us to broaden access to its genomics and integrated diagnostics solutions across India and other emerging markets,” the company said in a release.
 
Started in 2013, MedGenome offers over 1,300 genetic tests at over 6000 hospitals, which serve nearly 400 regions across the country.